T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRRX
2576
DELISTED
DURECT Corp
DRRX
| $310K | ﹤0.01% |
18,991
-506
| -3% | -$8.82K |
|
2577
Ingles Markets
IMKTA
$1.69B
| $310K | ﹤0.01% |
5,320
-1,449
| -21% | -$89.9K |
|
2578
BioXcel Therapeutics
BTAI
$34.9M
| $309K | ﹤0.01% |
664
-52
| -7% | -$28.3K |
|
|
OYST
2579
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $309K | ﹤0.01% |
17,990
-27,827
| -61% | -$529K |
|
2580
Sturm, Ruger & Co
RGR
$596M
| $308K | ﹤0.01% |
3,420
+323
| +10% | +$24.2K |
|
|
FUV
2581
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $308K | ﹤0.01% |
+896
| New | +$207K |
|
|
FRG
2582
DELISTED
Franchise Group, Inc.
FRG
| $307K | ﹤0.01% |
8,697
+789
| +10% | +$29K |
|
2583
National Healthcare
NHC
$3.48B
| $306K | ﹤0.01% |
4,378
+277
| +7% | +$20.1K |
|
|
NKLA
2584
DELISTED
Nikola Corporation Common Stock
NKLA
| $306K | ﹤0.01% |
+565
| New | +$235K |
|
2585
Designer Brands
DBI
$312M
| $305K | ﹤0.01% |
18,434
-3,178
| -15% | -$56K |
|
2586
Noodles & Co
NDLS
$101M
| $302K | ﹤0.01% |
3,023
+181
| +6% | +$16.8K |
|
2587
KALA BIO
KALA
$17M
| $301K | ﹤0.01% |
23
+6
| +35% | +$94.3K |
|
2588
Seaboard Corp
SEB
$4.04B
| $298K | ﹤0.01% |
77
-86
| -53% | -$322K |
|
2589
Global Industrial
GIC
$1.47B
| $296K | ﹤0.01% |
8,063
+351
| +5% | +$13.4K |
|
|
NFBK
2590
DELISTED
Northfield Bancorp
NFBK
| $296K | ﹤0.01% |
18,019
+1,465
| +9% | +$24.1K |
|
2591
Park Aerospace
PKE
$799M
| $296K | ﹤0.01% |
19,858
-4,672
| -19% | -$67.4K |
|
|
APTS
2592
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $296K | ﹤0.01% |
30,404
-6,282
| -17% | -$63.7K |
|
2593
LifeMD
LFMD
$160M
| $295K | ﹤0.01% |
+25,000
| New | +$288K |
|
|
MAGN
2594
Magnera Corp
MAGN
$436M
| $294K | ﹤0.01% |
1,621
+50
| +3% | +$9.84K |
|
|
SUP
2595
DELISTED
Superior Industries International
SUP
| $293K | ﹤0.01% |
34,000
-7,000
| -17% | -$48.1K |
|
2596
SI-BONE Inc
SIBN
$848M
| $290K | ﹤0.01% |
9,207
+664
| +8% | +$21.5K |
|
2597
Oportun Financial
OPRT
$354M
| $289K | ﹤0.01% |
14,427
+3,078
| +27% | +$63.1K |
|
2598
Energous
WATT
$89.5M
| $289K | ﹤0.01% |
168
+92
| +121% | +$167K |
|
2599
Krystal Biotech
KRYS
$9.89B
| $287K | ﹤0.01% |
4,219
+500
| +13% | +$34.9K |
|
|
CTO
2600
CTO Realty Growth
CTO
$825M
| $284K | ﹤0.01% |
15,924
+270
| +2% | +$4.78K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.